ATE517094T1 - Verfahren zur herstellung von medetomidin und seinen salzen - Google Patents

Verfahren zur herstellung von medetomidin und seinen salzen

Info

Publication number
ATE517094T1
ATE517094T1 AT07822154T AT07822154T ATE517094T1 AT E517094 T1 ATE517094 T1 AT E517094T1 AT 07822154 T AT07822154 T AT 07822154T AT 07822154 T AT07822154 T AT 07822154T AT E517094 T1 ATE517094 T1 AT E517094T1
Authority
AT
Austria
Prior art keywords
salts
medetomidine
producing
transmetalation
dimethylbenzaldehyde
Prior art date
Application number
AT07822154T
Other languages
English (en)
Inventor
Inese Reine
Armands Zandersons
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Application granted granted Critical
Publication of ATE517094T1 publication Critical patent/ATE517094T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT07822154T 2006-11-06 2007-11-02 Verfahren zur herstellung von medetomidin und seinen salzen ATE517094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06123548A EP1918282A1 (de) 2006-11-06 2006-11-06 Verfahren zur Herstellung von Medetomidine und ihre Salzen
PCT/EP2007/061822 WO2008055852A1 (en) 2006-11-06 2007-11-02 Method for preparing medetomidine and its salts

Publications (1)

Publication Number Publication Date
ATE517094T1 true ATE517094T1 (de) 2011-08-15

Family

ID=37770375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07822154T ATE517094T1 (de) 2006-11-06 2007-11-02 Verfahren zur herstellung von medetomidin und seinen salzen

Country Status (19)

Country Link
US (1) US7902377B2 (de)
EP (2) EP1918282A1 (de)
JP (1) JP2010508332A (de)
KR (1) KR20090052398A (de)
CN (1) CN101535272B (de)
AT (1) ATE517094T1 (de)
AU (1) AU2007316693B2 (de)
BR (1) BRPI0714992A2 (de)
CA (1) CA2660365C (de)
DK (1) DK2079706T3 (de)
EA (1) EA200900355A1 (de)
ES (1) ES2369746T3 (de)
MX (1) MX2009004649A (de)
NZ (1) NZ575125A (de)
PL (1) PL2079706T3 (de)
PT (1) PT2079706E (de)
SI (1) SI2079706T1 (de)
WO (1) WO2008055852A1 (de)
ZA (1) ZA200902607B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011070069A1 (en) 2009-12-09 2011-06-16 I-Tech Ab Process for preparation of medetomidine
CN102452984B (zh) * 2010-10-21 2013-10-23 桑迪亚医药技术（上海）有限责任公司 4-[1-(2,3-二甲基苯基)乙烯基]-1-r1-2-r2咪唑的合成方法
KR101932206B1 (ko) 2011-07-22 2018-12-24 캠브렉스 칼스코가 아베 4-치환 이미다졸의 신규 제조방법
US9045433B2 (en) 2012-05-08 2015-06-02 Lonza Ltd. Method for preparation of medetomidine
KR101537204B1 (ko) * 2012-05-08 2015-07-22 론자 아게 (론자 엘티디.) 2-(2,3-디메틸페닐)-1-프로파날의 제조 방법
WO2012172119A2 (en) 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
WO2012172122A2 (en) 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal
CA2866441C (en) 2012-06-28 2017-01-17 Lonza Ltd. Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal with chloroacetone
WO2012172121A1 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of medetomidine with chloroacetone
WO2013011157A1 (en) 2012-06-28 2013-01-24 Lonza Ltd Method for preparation of medetomidine with chloroacetone
CN103588711B (zh) * 2013-11-27 2015-04-08 天津炜捷制药有限公司 一种美托咪定中间体的制备方法
CN103664788B (zh) * 2013-12-04 2015-11-25 湖北生物医药产业技术研究院有限公司 制备美托咪啶的方法
CN104447562A (zh) * 2014-03-27 2015-03-25 宁波天衡药业股份有限公司 一种制备盐酸右美托咪定关键中间体的新方法
CN106083724B (zh) * 2016-08-02 2018-06-26 江苏恒瑞医药股份有限公司 一种右美托咪定的制备方法
CN111269192A (zh) * 2020-02-25 2020-06-12 成都睿智化学研究有限公司 一种5-羟甲基四氮唑及其衍生物的合成方法
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2069481B (en) 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
WO2006036497A2 (en) * 2004-09-24 2006-04-06 Allergan, Inc. 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
WO2006036480A1 (en) * 2004-09-24 2006-04-06 Allergan, Inc. 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists

Also Published As

Publication number Publication date
EP2079706A1 (de) 2009-07-22
US7902377B2 (en) 2011-03-08
PT2079706E (pt) 2011-10-19
EP1918282A1 (de) 2008-05-07
EA200900355A1 (ru) 2009-10-30
WO2008055852A8 (en) 2009-05-22
DK2079706T3 (da) 2011-10-03
ES2369746T3 (es) 2011-12-05
CA2660365A1 (en) 2008-05-15
BRPI0714992A2 (pt) 2013-07-30
CN101535272B (zh) 2011-10-05
EP2079706B1 (de) 2011-07-20
CN101535272A (zh) 2009-09-16
WO2008055852A1 (en) 2008-05-15
KR20090052398A (ko) 2009-05-25
US20100048915A1 (en) 2010-02-25
ZA200902607B (en) 2010-04-28
JP2010508332A (ja) 2010-03-18
CA2660365C (en) 2014-03-25
NZ575125A (en) 2011-02-25
AU2007316693A1 (en) 2008-05-15
PL2079706T3 (pl) 2011-12-30
MX2009004649A (es) 2009-05-21
SI2079706T1 (sl) 2011-11-30
AU2007316693B2 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
ATE517094T1 (de) Verfahren zur herstellung von medetomidin und seinen salzen
TW200738270A (en) Method of treating depression using a TNFα antibody
ATE510838T1 (de) Verfahren zur herstellung von 2-methyl-1-(2- methylpropyl)-1h-imidazoä4,5-cüä1,5ünaphthyridi - 4-amin
DE602004020538D1 (de) Verfahren und Vorrichtung zur Laserbestrahlung, sowie Verfahren zur Herstellung von Halbleiter.
AT9435U3 (de) Kopierfräseinrichtung zur herstellung von insbesondere zahntechnischen werkstücken
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
SG166091A1 (en) Method for producing isocyanates
TW200732447A (en) Adhesive formulation, method for the production thereof, and use thereof
DE502004009142D1 (de) Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
IL185031A0 (en) Method for the preparation of pregabalin and salts thereof
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE449096T1 (de) Verfahren zur herstellung von 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-p enoxypropyl)-1- azoniabicycloä2.2.2üoctanbromid
EA201070689A1 (ru) Композиция для личного ухода
WO2008085900A3 (en) Methods for generating novel stabilized proteins
DE602006017480D1 (de) Oxidkomplexlaminat, Verfahren zur Herstellung eines Oxidkomplexlaminats und Vorrichtung
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
EP1848580A4 (de) Vorrichtung und verfahren zur herstellung von wellpappe und kaschiertem karton sowie darauf beruhende zusammensetzungen
DE602004004677D1 (de) Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine
ATE466843T1 (de) Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
WO2010148177A3 (en) Compounds, compositions, methods of synthesis, and methods of treatment
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
ATE414796T1 (de) Mittel zur herstellung von leder

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2079706

Country of ref document: EP